Mogamulizumab for Adult T-Cell Leukemia/Lymphoma Associated With Increased Mortality

Patients with adult T-cell leukemia/lymphoma treated with mogamulizumab prior to undergoing allo-HSCT were at significantly greater risk for graft-vs-host disease –related mortality.

Source: CancerNetwork - August 17, 2016 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Hematologic Malignancies Leukemia & Lymphoma News Source Type: news